Literature DB >> 10852832

Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain.

J W Olney1, N B Farber, D F Wozniak, V Jevtovic-Todorovic, C Ikonomidou.   

Abstract

We review recent findings pertaining to several environmental agents (ethanol, phencyclidine, ketamine, nitrous oxide, barbiturates, benzodiazepines, halothane, isoflurane, and propofol) that have the potential to delete large numbers of neurons from the developing brain by a newly discovered mechanism involving interference in the action of neurotransmitters [glutamate and gamma-amino butyric acid (GABA) at (italic)N(/italic)-methyl-d-aspartate (NMDA)] and GABA(subscript)A(/subscript) receptors during the synaptogenesis period, also known as the brain growth-spurt period. Transient interference (lasting >= 4 hr) in the activity of these transmitters during the synaptogenesis period (the last trimester of pregnancy and the first several years after birth in humans) causes millions of developing neurons to commit suicide (die by apoptosis). Many of these agents are drugs of abuse (ethanol is a prime example) to which the human fetal brain may be exposed during the third trimester by drug-abusing mothers. Ethanol triggers massive apoptotic neurodegeneration in the developing brain by interfering with both the NMDA and GABA(subscript)A(/subscript) receptor systems, and this can explain the reduced brain mass and lifelong neurobehavioral disturbances associated with intrauterine exposure of the human fetus to ethanol (fetal alcohol syndrome). Exposure of the immature brain in a medical treatment context is also of concern because many of these agents are drugs used frequently as sedatives, tranquilizers, anticonvulsants, or anesthetics in pediatric and/or obstetrical medicine. Because this is a newly discovered mechanism, further research will be required to fully ascertain the nature and degree of risk posed by exposure of the developing human brain to environmental agents that act by this mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852832      PMCID: PMC1637813          DOI: 10.1289/ehp.00108s3383

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  43 in total

Review 1.  NMDA receptor hypofunction model of schizophrenia.

Authors:  J W Olney; J W Newcomer; N B Farber
Journal:  J Psychiatr Res       Date:  1999 Nov-Dec       Impact factor: 4.791

2.  Comparative aspects of the brain growth spurt.

Authors:  J Dobbing; J Sands
Journal:  Early Hum Dev       Date:  1979-03       Impact factor: 2.079

Review 3.  Excitatory amino acids and neuropsychiatric disorders.

Authors:  J W Olney
Journal:  Biol Psychiatry       Date:  1989-09       Impact factor: 13.382

Review 4.  Glutamate and the pathophysiology of hypoxic--ischemic brain damage.

Authors:  S M Rothman; J W Olney
Journal:  Ann Neurol       Date:  1986-02       Impact factor: 10.422

5.  Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate.

Authors:  J W Olney
Journal:  Science       Date:  1969-05-09       Impact factor: 47.728

6.  Excitotoxic amino acids as neuroendocrine research tools.

Authors:  J W Olney; M T Price
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists.

Authors:  S H Kim; M T Price; J W Olney; N B Farber
Journal:  Mol Psychiatry       Date:  1999-07       Impact factor: 15.992

8.  N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production.

Authors:  P L Hoffman; C S Rabe; F Moses; B Tabakoff
Journal:  J Neurochem       Date:  1989-06       Impact factor: 5.372

9.  Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs.

Authors:  J W Olney; J Labruyere; M T Price
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  28 in total

1.  Persistent dose-dependent changes in brain structure in young adults with low-to-moderate alcohol exposure in utero.

Authors:  Kristen L Eckstrand; Zhaohua Ding; Neil C Dodge; Ronald L Cowan; Joseph L Jacobson; Sandra W Jacobson; Malcolm J Avison
Journal:  Alcohol Clin Exp Res       Date:  2012-05-17       Impact factor: 3.455

2.  Neonatal treatment with a competitive NMDA antagonist results in response-specific disruption of conditioned fear in preweanling rats.

Authors:  Pamela S Hunt
Journal:  Psychopharmacology (Berl)       Date:  2006-01-17       Impact factor: 4.530

3.  [Does anesthesia damage children's brains?].

Authors:  M Jöhr
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

4.  Association of prenatal and early life exposure to tetrachloroethylene (PCE) with polycystic ovary syndrome and other reproductive disorders in the cape cod health study: A retrospective cohort study.

Authors:  Shruthi Mahalingaiah; Michael R Winter; Ann Aschengrau
Journal:  Reprod Toxicol       Date:  2016-07-10       Impact factor: 3.143

Review 5.  Long-term Neurotoxic Effects of Early-life Exposure to Tetrachloroethylene-contaminated Drinking Water.

Authors:  Ann Aschengrau; Patricia A Janulewicz; Roberta F White; Veronica M Vieira; Lisa G Gallagher; Kelly D Getz; Thomas F Webster; David M Ozonoff
Journal:  Ann Glob Health       Date:  2016 Jan-Feb       Impact factor: 2.462

6.  Long-term action of propofol on cognitive function and hippocampal neuroapoptosis in neonatal rats.

Authors:  Dan Han; Jianhua Jin; Hao Fang; Guoxiong Xu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 7.  Early childhood general anaesthesia exposure and neurocognitive development.

Authors:  L Sun
Journal:  Br J Anaesth       Date:  2010-12       Impact factor: 9.166

8.  Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD.

Authors:  Anders Fredriksson; Trevor Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

9.  Hyperactivity following postnatal NMDA antagonist treatment: reversal by D-amphetamine.

Authors:  Anders Fredriksson; Trevor Archer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 10.  Glutamate antagonists are neurotoxins for the developing brain.

Authors:  Angela M Kaindl; Chrysanthy Ikonomidou
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.